Institute of Chemical Technology (ICT), Mumbai has received a prestigious grant from Bill & Melinda Gates Foundation to develop the first green nanovaccine for nasal immunization against brucellosis. Prof. Vandana Patravale, ICT, Matunga was awarded USD100,000 in phase I of Grand Challenges Explorations Round 11 for developing the cost-effective vaccine technology from over 2700 applications. The sub-unit nanovaccine aims to confer long term protective immunity to humans and livestock population. Currently, Brucellosis is a zoonotic bacterial infection with a potential to be exploited as a bioweapon, and currently no human vaccine is available for treatment
|11,950 ₹||4950 ₹||4950 ₹||4950 ₹||3950 ₹|
Copyright © 2013 Ibis Research Information Services Pvt Ltd. All Rights Reserved.
Contact : Ibis Research Information Services Pvt Ltd., 28, Rajaji Street, NGO Colony